Synapse topology and downmodulation events determine the functional outcome of anti-CD19 T cell-redirecting strategies

Bibliographic Details
Title: Synapse topology and downmodulation events determine the functional outcome of anti-CD19 T cell-redirecting strategies
Authors: Ángel Ramírez-Fernández, Óscar Aguilar-Sopeña, Laura Díez-Alonso, Alejandro Segura-Tudela, Carmen Domínguez-Alonso, Pedro Roda-Navarro, Luis Álvarez-Vallina, Belén Blanco
Source: OncoImmunology, Vol 11, Iss 1 (2022)
Publisher Information: Taylor & Francis Group, 2022.
Publication Year: 2022
Collection: LCC:Immunologic diseases. Allergy
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: CD19+ B cell malignancies, T cell-redirecting strategies, STAb, BiTE, CAR, leukemia relapse, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Cancer immunotherapy strategies based on the endogenous secretion of T cell-redirecting bispecific antibodies by engineered T lymphocytes (STAb-T) are emerging as alternative or complementary approaches to those based on chimeric antigen receptors (CAR-T). The antitumor efficacy of bispecific anti-CD19 × anti-CD3 (CD19×CD3) T cell engager (BiTE)-secreting STAb-T cells has been demonstrated in several mouse models of B-cell acute leukemia. Here, we have investigated the spatial topology and downstream signaling of the artificial immunological synapses (IS) that are formed by CAR-T or STAb-T cells. Upon interaction with CD19-positive target cells, STAb-T cells form IS with structure and signal transduction, which more closely resemble those of physiological cognate IS, compared to IS formed by CAR-T cells expressing a second-generation CAR bearing the same CD19-single-chain variable fragment. Importantly, while CD3 is maintained at detectable levels on the surface of STAb-T cells, indicating sustained activation mediated by the secreted BiTE, the anti-CD19 CAR was rapidly downmodulated, which correlated with a more transient downstream signaling. Furthermore, CAR-T cells, but not STAb-T cells, provoke an acute loss of CD19 in target cells. Such differences might represent advantages of the STAb-T strategy over the CAR-T approach and should be carefully considered in order to develop more effective and safer treatments for hematological malignancies.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2162402X
2162-402X
Relation: https://doaj.org/toc/2162-402X
DOI: 10.1080/2162402X.2022.2054106
Access URL: https://doaj.org/article/a738330a8b26462fa166a9c5d196ff70
Accession Number: edsdoj.738330a8b26462fa166a9c5d196ff70
Database: Directory of Open Access Journals
More Details
ISSN:2162402X
DOI:10.1080/2162402X.2022.2054106
Published in:OncoImmunology
Language:English